(MedPage Today) -- Did a top surgeon do a nonrandomized trial without consulting IRB or patients?
via CardioBrief: Eminence-Based Medicine and Cardiac Surgery
by
Sunday, July 31, 2016
Saturday, July 30, 2016
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include the cost of physical inactivity, the mortality impact of sedentary behavior, behavioral activation for depression, and skin inspections for skin cancer
via PodMed: A Medical News Roundup From Johns Hopkins (with audio)
by
via PodMed: A Medical News Roundup From Johns Hopkins (with audio)
by
Friday, July 29, 2016
Absorb Stent: Thrombosis Still a Concern Longer-Term (CME/CE)
(MedPage Today) -- Adverse event rate otherwise 'acceptable' in 18-month registry data
via Absorb Stent: Thrombosis Still a Concern Longer-Term (CME/CE)
by
via Absorb Stent: Thrombosis Still a Concern Longer-Term (CME/CE)
by
Full-Dose NOAC Safe With Single Dose-Reduction Factor (CME/CE)
(MedPage Today) -- "Should be the preferred dose" of apixaban (Eliquis) unless more factors
via Full-Dose NOAC Safe With Single Dose-Reduction Factor (CME/CE)
by
via Full-Dose NOAC Safe With Single Dose-Reduction Factor (CME/CE)
by
Flu Shot Cuts CVD in T2D; TAVR Leak Blood Test; HFpEF Survival Up
(MedPage Today) -- Cardiovascular Daily wraps up the top cardiology news of the week
via Flu Shot Cuts CVD in T2D; TAVR Leak Blood Test; HFpEF Survival Up
by
via Flu Shot Cuts CVD in T2D; TAVR Leak Blood Test; HFpEF Survival Up
by
Improved T2DM Survival Fuels Higher Prevalence (CME/CE)
(MedPage Today) -- Scottish study results mirror those of other countries
via Improved T2DM Survival Fuels Higher Prevalence (CME/CE)
by
via Improved T2DM Survival Fuels Higher Prevalence (CME/CE)
by
EndoBreak: Obesity Drug Spiked; Fossil Clues to Vit D
(MedPage Today) -- News and commentary from the endocrinology world
via EndoBreak: Obesity Drug Spiked; Fossil Clues to Vit D
by
via EndoBreak: Obesity Drug Spiked; Fossil Clues to Vit D
by
Subscribe to:
Posts (Atom)